A NEPHROHUB masterclass organized by the Department of Nephrology and Renal Replacement Therapy addressed one of the key challenges in nephrology: the management of arterial hypertension in patients with chronic kidney disease (CKD) across the full spectrum of treatment stages — from pre-dialysis to kidney transplantation.

Hypertension, as a principal pathophysiological factor in CKD progression, remains a complex therapeutic target. Participants examined current evidence and clinical strategies for blood pressure control in diverse settings, including ambulatory care, dialysis, and post-transplantation monitoring.

Key discussion points included:

• validated blood pressure measurement techniques in CKD;
• treatment algorithms stratified by CKD stages 1–3 and 4–5;
• individualized drug selection based on renal replacement modality.

The event underscored the shift from rigid antihypertensive protocols to adaptive, evidence-based approaches that consider laboratory data, hemodynamic parameters, and clinical context.

Bringing together specialists from multiple disciplines, the masterclass reaffirmed that arterial hypertension in CKD is not a static number, but a dynamic, multifactorial clinical domain, requiring personalized therapeutic strategies grounded in precision medicine.